UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments

Brain research, 2008-05, Vol.1211, p.37-43

2008

Volltextzugriff (PDF)

Anxiolytic-like activity of oxytocin in male mice : behavioral and autonomic evidence, therapeutic implications

Psychopharmacologia, 2006-04, Vol.185 (2), p.218-225

2006

Volltextzugriff (PDF)

Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression

Neuropharmacology, 2013-03, Vol.66, p.202-214

2013

Volltextzugriff (PDF)

Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs

Current pharmaceutical design, 2005, Vol.11 (2), p.145-155

2005

Volltextzugriff (PDF)

Innovative Approaches for the Development of Antidepressant Drugs: Current and Future Strategies

NeuroRx, 2005-10, Vol.2 (4), p.590-611

2005

Volltextzugriff (PDF)

Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties

The Journal of pharmacology and experimental therapeutics, 2005-09, Vol.314 (3), p.1274-1289

2005

Volltextzugriff (PDF)

Ketanserin and ritanserin discriminate between recombinant human 5-HT1Dα and 5-HT1Dβ receptor subtypes

European journal of pharmacology, 1995-09, Vol.291 (1), p.9-15

1995

Volltextzugriff (PDF)

Discovery of 5-Arylsulfonamido-3- (pyrrolidin-2-ylmethyl)-1H-indole Derivatives as Potent, Selective 5-HT6 Receptor Agonists and Antagonists

Journal of medicinal chemistry, 2005-01, Vol.48 (2), p.353-356

2005

Volltextzugriff (PDF)

Concomitant blockade of 5-HT1A receptor and 5-HT transporter: Use of the Hunter Serotonin Toxicity Criteria in a clinical pharmacology study

European neuropsychopharmacology, 2012-02, Vol.22 (2), p.92-99

2012

Volltextzugriff (PDF)

βSubunits Promote K + Channel Surface Expression through Effects Early in Biosynthesis

Neuron (Cambridge, Mass.), 1996-04, Vol.16 (4), p.843-852

1996

Volltextzugriff (PDF)

The Potential Utility of 5-HT1A Receptor Antagonists in the Treatment of Cognitive Dysfunction Associated with Alzheimers Disease

Current pharmaceutical design, 2002-01, Vol.8 (2), p.139-145

2002

Volltextzugriff (PDF)

Studies toward the Discovery of the Next Generation of Antidepressants. 3. Dual 5-HT1A and Serotonin Transporter Affinity within a Class of N-Aryloxyethylindolylalkylamines

Journal of medicinal chemistry, 2004-07, Vol.47 (15), p.3823-3842

2004

Volltextzugriff (PDF)

1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands

Bioorganic & medicinal chemistry letters, 2004-11, Vol.14 (22), p.5499-5502

2004

Volltextzugriff (PDF)

Studies toward the discovery of the next generation of antidepressants. Part 5 : 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives with dual 5-HT1A receptor and serotonin transporter affinity

Bioorganic & medicinal chemistry letters, 2006-03, Vol.16 (5), p.1338-1341

2006

Volltextzugriff (PDF)

Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon

Neuropeptides (Edinburgh), 2007-10, Vol.41 (5), p.307-320

2007

Volltextzugriff (PDF)

Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine

Brain research, 2008-04, Vol.1203, p.68-78

2008

Volltextzugriff (PDF)

Major depressive disorder

Current pharmaceutical design, 2005, Vol.11 (2), p.143

Schechter, Lee E

2005

Volltextzugriff (PDF)

Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex

Journal of psychopharmacology (Oxford), 2002-06, Vol.16 (2), p.145-152

2002

Volltextzugriff (PDF)

Effects of chronic fluoxetine treatment in the presence and absence of (±)pindolol: a microdialysis study

British journal of pharmacology, 2000-06, Vol.130 (4), p.797-804

2000

Volltextzugriff (PDF)

Studying Rat Brain Neurochemistry Using Nanoprobe NMR Spectroscopy: a Metabonomics Approach

Analytical chemistry (Washington), 2004-07, Vol.76 (14), p.4123-4127

2004

Volltextzugriff (PDF)

Preclinical characterization of WAY‐211612: a dual 5‐HT uptake inhibitor and 5‐HT1A receptor antagonist and potential novel antidepressant

British journal of pharmacology, 2009-05, Vol.157 (2), p.307-319

2009

Volltextzugriff (PDF)

Regulators of G-protein signaling 4: modulation of 5-HT1A-mediated neurotransmitter release in vivo

Brain research, 2004-10, Vol.1022 (1-2), p.214-220

2004

Volltextzugriff (PDF)

The potassium channel blockers 4-aminopyridine and tetraethylammonium increase the spontaneous basal release of [3H]5-hydroxytryptamine in rat hippocampal slices

The Journal of pharmacology and experimental therapeutics, 1997-07, Vol.282 (1), p.262

Schechter, L E

1997

Volltextzugriff (PDF)

Preclinical characterization of WAY‐211612: a dual 5‐HT uptake inhibitor and 5‐HT 1A receptor antagonist and potential novel antidepressant

British journal of pharmacology, 2009-05, Vol.157 (2), p.307-319

2009

Volltextzugriff (PDF)

Nanoprobe NMR spectroscopy and in vivo microdialysis: new analytical methods to study brain neurochemistry

Journal of neuroscience methods, 2004-02, Vol.133 (1), p.181-189

2004

Volltextzugriff (PDF)

1 – 25 von 156

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(114)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(81)
Life Sciences & Biomedicine
(80)
Humans
(54)
Biological And Medical Sciences
(44)
Male
(41)
Medical Sciences
(36)
Pharmacology & Pharmacy
(33)
Animals
(31)
Rats
(23)
Pharmacology. Drug Treatments
(21)
Aids/hiv
(20)
Neuropharmacology
(20)
Neurosciences & Neurology
(18)
Neurosciences
(17)
Female
(16)
Adult
(15)
Psychology. Psychoanalysis. Psychiatry
(14)
Human Immunodeficiency Virus
(13)
Serotonin Antagonists - Pharmacology
(13)
Chemistry, Medicinal
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments

Anxiolytic-like activity of oxytocin in male mice : behavioral and autonomic evidence, therapeutic implications

Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression

Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs

Innovative Approaches for the Development of Antidepressant Drugs: Current and Future Strategies

Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties

Ketanserin and ritanserin discriminate between recombinant human 5-HT1Dα and 5-HT1Dβ receptor subtypes

Discovery of 5-Arylsulfonamido-3- (pyrrolidin-2-ylmethyl)-1H-indole Derivatives as Potent, Selective 5-HT6 Receptor Agonists and Antagonists

Concomitant blockade of 5-HT1A receptor and 5-HT transporter: Use of the Hunter Serotonin Toxicity Criteria in a clinical pharmacology study

βSubunits Promote K + Channel Surface Expression through Effects Early in Biosynthesis

The Potential Utility of 5-HT1A Receptor Antagonists in the Treatment of Cognitive Dysfunction Associated with Alzheimers Disease

Studies toward the Discovery of the Next Generation of Antidepressants. 3. Dual 5-HT1A and Serotonin Transporter Affinity within a Class of N-Aryloxyethylindolylalkylamines

1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands

Studies toward the discovery of the next generation of antidepressants. Part 5 : 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives with dual 5-HT1A receptor and serotonin transporter affinity

Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon

Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine

Major depressive disorder

Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex

Effects of chronic fluoxetine treatment in the presence and absence of (±)pindolol: a microdialysis study

Studying Rat Brain Neurochemistry Using Nanoprobe NMR Spectroscopy: a Metabonomics Approach

Preclinical characterization of WAY‐211612: a dual 5‐HT uptake inhibitor and 5‐HT1A receptor antagonist and potential novel antidepressant

Regulators of G-protein signaling 4: modulation of 5-HT1A-mediated neurotransmitter release in vivo

The potassium channel blockers 4-aminopyridine and tetraethylammonium increase the spontaneous basal release of [3H]5-hydroxytryptamine in rat hippocampal slices

Preclinical characterization of WAY‐211612: a dual 5‐HT uptake inhibitor and 5‐HT 1A receptor antagonist and potential novel antidepressant

Nanoprobe NMR spectroscopy and in vivo microdialysis: new analytical methods to study brain neurochemistry

Suchergebnisse filtern